Watchlist Price Alert

Altamira Therapeutics Ltd... (CYTO)

NASDAQ: CYTO · Real-Time Price · USD

0.30

0.00 (0.00%)

At close: Jan 16, 2025, 9:00 PM

Altamira Therapeutics Cash Flow Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-3.87M	-26.53M	-17.39M	-8.2M	-6.63M	-11.5M	-24.41M	-30.66M
Depreciation & Amortization	119.3K	118.89K	76.36K	20.04K	30.82K	72.71K	122.78K	97.6K
Stock-Based Compensation	n/a	342.8K	1.21M	368.79K	226.6K	27.73K	354.85K	290.78K
Other Working Capital	-3.92M	2.73M	1.35M	46.09K	-1.21M	-3.09M	168.98K	-360.55K
Other Non-Cash Items	-3.42M	13.83M	1.9M	2.69M	-601.08K	474.7K	142.04K	679.38K
Deferred Income Tax	-99.85K	-10.33K	21.62K	-21.28K	-193.84K	162.18K	-17.77K	-131.06K
Change in Working Capital	-4.24M	3.56M	511.11K	300.52K	-1.22M	-2.47M	-468.19K	271.93K
Operating Cash Flow	-11.51M	-8.68M	-13.67M	-4.84M	-8.39M	-13.23M	-24.28M	-29.45M
Capital Expenditures	n/a	-2.14M	-3.33M	-2.32M	-3.02M	-1.89M	-152.97K	-244.32K
Cash Acquisitions	1.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-179.1K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	10.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	505.00	969.00	-179.1K	258.00	17.88K	68.16K	53.57K	67.55K
Investing Cash Flow	1.44M	-2.14M	-3.51M	-2.31M	-3M	-1.82M	-99.4K	-176.77K
Debt Repayment	1.05M	5.92M	-68.7K	1.52M	-1.46M	-9.27M	-2.09M	11.99M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.57M	3.91M	6.68M	15.44M	-952.36K	-2.44M	-2.73M	-548.03K
Financial Cash Flow	10.62M	9.83M	6.61M	16.96M	7.38M	5.73M	8.22M	11.44M
Net Cash Flow	602.01K	-968.8K	-10.27M	9.87M	-4.01M	-9.58M	-17.47M	-17.8M
Free Cash Flow	-11.51M	-10.83M	-17M	-7.16M	-11.41M	-15.12M	-24.43M	-29.7M